SPY304.32+1.52 0.50%
DIA254.29+0.10 0.04%
IXIC9,489.87+120.88 1.29%

Myriad Receives FDA Approval Of BRACAnalysis CDx As A Companion Diagnostic For Lynparza In HRR-Mutated Metastatic Castration-Resistant Prostate Cancer

Benzinga · 05/20/2020 11:07